Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

PAPERBACK price:$33.00 add to cart Rights & Permissions Free PDF Access Sign in to download PDF book and chapters Free Resources PDF SUMMARY Display this book on your site! Related Titles Contraceptive Research and Development:Looking to the Future Biologic Markers in Reproductive Toxicology Other Related Titles Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda (1993) Institute of Medicine (IOM) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "Appendix B: Background Papers and Presentations (In Order of Presentation at IOM Workshop)." Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press, 1993. Please select a format: Page 69   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. B Background Papers and Presentations (In Order of Presentation at IOM Workshop) Page 69 Front Matter (R1-R14) Summary (1-13) INtroduction (14-18) Uses of Antiprogestins: The Reproductive Cycle (Part I) (19-25) Uses of Antiprogestins: The Reproductive Cycle (Part II) (26-35) Other Therapeutic Uses of Antiprogestins (36-51) Antiglucocorticoid Effects of Antiprogestins (52-56) Animals as Models for Studying Antiprogestins (57-62) Appendix A: Agenda fr the IOM Workshop 'Antiprogestins: Assessing the Science' (63-68) Appendix B: Background Papers and Presentations (In Order of Presentation at IOM Workshop) (69-70) B1. 1993: RU 486--A Decade on Today and Tomorrow (71-119) B2. Overview and Background: Mechanism of Action of Antiprogestins (120-138) B3. The Use of Antiprogestins in the Reproductive Cycle (139-147) B4. Potential Contraceptive Effects of Antigestogens (148-163) B5. Use of Antiprogestins Before 63 Days of Amenorrhea (164-173) B6. Uses of Antiprogestins After 63 Days of Amenorrhea (174-182) B7. Comments on Session II (183-188) B8. Use of Antiprogestins in the Management of Endometriosis and Leiomyoma (189-209) B9. Antiprogestins and the Treatment of Breast Cancer (210-228) B10. Uses of RU 486 as an Antiglucocoticoid (229-242) B11. Primate Models for the Study of Antiprogestins in Reproductive Medicine (243-252) B12. ANtiprogestogens: Perspectives from a Global Research Program (253-277) Appendix C: Observers at the Workshop on Antiprogestins (278-280) Index (281-288)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 69
Clinical Applications of Mifepristone (RU 486) and other Antiprogestins: Assessing the Science and Recommending a Research Agenda B Background Papers and Presentations (In Order of Presentation at IOM Workshop)

OCR for page 70
Clinical Applications of Mifepristone (RU 486) and other Antiprogestins: Assessing the Science and Recommending a Research Agenda This page in the original is blank.

Representative terms from entire chapter:

research agenda